Avanti Polar Lipids

Avanti Research, founded in 1967 and acquired by Croda International Plc in 2012, is the foundational supplier of high-purity lipids for scientific research and pharmaceutical development. Its core strategy leverages unparalleled expertise in lipid chemistry and purification to provide the critical materials for lipid nanoparticle (LNP) delivery systems, enabling partners across the biopharma industry. The company has successfully transitioned from a premier research reagent supplier to an integrated, scalable partner for therapeutic commercialization, capitalizing on the explosive growth of mRNA and nucleic acid therapeutics.

Mastery of lipid chemistry, synthesis, and purification, providing high-purity lipid components and formulation expertise for lipid nanoparticle (LNP) and other advanced drug delivery systems.

Avanti holds a dominant position due to its unparalleled purity standards, vertical integration, and strong brand. It faces fragmented competition from research chemical suppliers lacking GMP scale and from pharmaceutical CDMOs lacking its novel lipid discovery expertise.